Skip to main content

Table 3 Prevalence of cardiovascular autonomic neuropathy and parameters for the evaluation of cardiovascular parasympathetic and sympathetic nervous system in patients with congenital generalized lipodistrophy, type 1 diabetes and healthy individuals

From: Early commitment of cardiovascular autonomic modulation in Brazilian patients with congenital generalized lipodystrophy

Variables

CGL (n = 10)

Type 1 diabetes (n = 20)

Healthy (n = 20)

p1

p2

p3

Clinical CAN % (n)

40 (4)

5 (1)

0

0.031

0.008

1.000

Incipient CAN % (n)

10 (1)

15 (3)

0

1.000

0.333

0.115

CAN % (n)

50 (5)

20 (4)

0

0.115

0.002

0.106

Altered 30/15 coefficient % (n)

40 (4)

15 (3)

0

0.181

0.008

0.231

Altered Valsalva coefficient % (n)

10 (1)

0

0

0.333

0.333

1.000

Altered E/I coefficient % (n)

30 (3)

5 (1)

0

0.095

0.030

1.000

Postural hypotension % (n)

10 (1)

0

0

0.333

0.333

1.000

Parasympathetic System

30/15 coefficient

1.19

(0.98; 1.59)

1.34

(1.04; 1.68)

1.55

(2.26; 2.02)

0.064

0.001

0.001

E/I coefficient

1.33

(1.09; 1.57)

1.52

(1.14; 2.01)

1.60

(1.23; 2.23)

0.004

0.001

0.323

Component of high frequency (Hz)

627

(55; 1840)

1447

(182; 8374)

2993

(270; 9969)

0.019

0.001

0.064

SDNN

64

(22; 169)

60

(25; 124)

82

(36; 163)

0.965

0.113

0.039

RMSSD

57

(12; 237)

52

(17; 170)

85

(18; 180)

0.877

0.252

0.069

Sympathetic system

Reduction in SBP

>10 mmHg % (n)

30 (3)

10 (2)

5 (1)

0.300

0.095

1.000

Reduction in SBP > 20 mmHg % (n)

10 (1)

0

0

0.333

0.333

1.000

Component of very low frequency (Hz)

383

(88; 4250)

1077

(392; 5857)

1988

(688; 18,341)

0.017

0.002

0.026

Parasympathetic and sympathetic systems

Valsalva coefficient

1.54

(1.15; 2.34)

1.70

(1.24; 2.52)

1.74

(1.50; 2.42)

0.166

0.039

0.297

Component of low frequency (Hz)

329

(139; 2525)

972

(181; 3109)

1916

(343; 5580)

0.033

0.001

0.017

Total spectrum amplitude (Hz)

1582

(501;9691)

4482

(755; 12,854)

7125

(1853; 24,788)

0.019

0.000

0.013

LF/HF ratio

1.21

(0.12; 3.70)

0.67

(0.19; 1.99)

0.58

(0.26; 1.70)

0.235

0.454

0.892

  1. CGL congenital generalized lipodystrophy, CAN cardiovascular autonomic neuropathy, 30/15 orthostatic coefficient, E/I respiratory coefficient, SDNN standard deviation of the RR interval average, RMSSD square root of the RR interval average, SBP systolic blood pressure, LF/HF Low frequency/high frequency component. Tests: Fischer’s exact test; Mann-Whitney test; p1: comparison between CGL and type 1 diabetes groups; p2: comparison between CGL and healthy groups; p3: comparison between type 1 diabetes and healthy individuals. Statistical significance p < 0.050 are marked in italic